Advancing Cancer Therapy: Harnessing In Vivo Tumor Models for Breakthrough Drug Development
Registration link:
https://www.eventbrite.com/e/1021029977147?aff=oddtdtcreator
Date:
Wednesday, Oct 2nd, 2024; 11:00 am PST, or 2:00 pm EST
Webinar Highlights:
Join us for an insightful webinar exploring the critical role of in vivo tumor models in advancing cancer drug therapy. We will provide an overview of the diverse tumor models developed by our company, highlighting case studies demonstrating their effectiveness in preclinical cancer research. The session will delve into the comprehensive use of gene-modified cell lines and genetically modified spontaneous mouse models, showcasing their application in mimicking human cancer biology. We will conclude with a brief introduction to our company and our commitment to accelerating cancer drug development through innovative animal modeling services.
This webinar is ideal for researchers, drug developers, and anyone involved in cancer therapy seeking to understand the latest advancements in tumor modeling.
Meet Our Speaker:
Dr. Juan (Jane) Hong earned her Bachelor's degree and Ph.D. from Nanjing Medical University in 2017, specializing in neuroinflammation and molecular biology related to central nervous system (CNS) diseases. She then furthered her research at the University of Nebraska and Washington University in St. Louis, dedicating six years to studying biomarkers across various diseases, with a particular focus on immuno-oncology. In 2022, Jane joined the International Industrial Client Department at GenoBioTX as a Senior Marketing Manager, where she has been involved in numerous projects evaluating small and large molecules in various cancer models. Her career has been marked by extensive experience in developing and assessing drug candidates in preclinical models.
About GenoBioTX
GenoBioTX provides comprehensive animal modeling services, ranging from model construction to preclinical in vitro and in vivo assays, based on the combination of versatile technical platforms and experienced scientist.
Contact us
Website: www.genobiotx.com
Email: info@genobiotx.com
Address: 10410 Corporate Dr., Sugar Land, TX, 77478, USA
You may also like
Cre-ERT2在无Tamoxifen诱导的情况下，在细胞质内处于无活性状态；当Tamoxifen诱导后，Tamoxifen的代谢产物4-OHT（雌激素类似物）与ERT结合，可使Cre-ERT2进核发挥Cre重组酶活性。
Learn more你一定听说过Cre-lox重组系统，无论你是否直接进行过基因操作。由于Cre-lox系统具有操作简单、重组率高的优点，如今已经成为体内外遗传操作的强有力工具。利用Cre-lox系统，可以在特定细胞、组织或整个生物体，甚至在特定时间点敲除或表达某个基因，实现对特定基因的时空特异性操作，这对基因功能的研究和人类疾病动物模型的建立都具有深刻影响。
Learn more
